Newsletter

006280 - GC Biopharma Corp.

006280 Summary
Biopharma
Stock Price & Overview
₩127,600 +600 (+0.47%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩127,600  ≈ US$91  ·  Market cap ₩1.5tn (≈ $1.1bn)
Home › 006280 › Filings

Corporate governance report

DART
GC Biopharma Corp.
Filed Jun 1, 2026 KST · Filing · receipt 20260601801289

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 기업지배구조보고서공시

006280

Price
₩127,600
Change
+0.47%
Market cap
₩1.5tn
Prev. close
₩127,000
006280 SummaryCompare to Peers

More 006280 filings

Half-Year Report

08/14/26

Insider / Major Shareholder Holdings Report

08/07/26

Fair-trade compliance programme status (notice)

07/31/26

Preliminary Consolidated Results (Fair Disclosure)

07/31/26

New Facility Investment

07/16/26

Material event report (disposal of shares in another company)

07/10/26